MICHAEL REGAN: Open Payments
NPI 1831575687 · LISLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,446 in 201 payments from 21 companies in 2025. Trend: 2023 $2,491 · 2024 $2,561 · 2025 $3,446
Food & beverage: $3,355Education: $91
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $498 |
| Novartis Pharmaceuticals Corporation | 20 | $473 |
| Janssen Biotech, Inc. | 19 | $453 |
| MAYNE PHARMA COMMERCIAL LLC | 30 | $330 |
| Arcutis Biotherapeutics, Inc. | 28 | $230 |
| PFIZER INC. | 10 | $218 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $181 |
| Organon LLC | 14 | $181 |
| LEO Pharma Inc. | 13 | $144 |
| GENZYME CORPORATION | 4 | $121 |
Products named: TREMFYA, COSENTYX, RINVOQ, SKYRIZI, Zoryve, LITFULO, DUPIXENT, ILUMYA.
Industry payments across IL — which companies pay providers there.
